Achieved $50.3 million in total net revenue and $48.1 million in net product revenue for the first quarter of 2024, representing year over year growth of approximately 46% and 40% respectively, and.
In recognition of Lupus Awareness Month, Aurinia Pharmaceuticals Inc. , today announced several initiatives to improve understanding of the seriousness of lupus nephritis and the need for frequent.
New data showing sustained complete renal response with LUPKYNIS through three years Monthly kidney function assessment no longer required after first year…
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Short Interest Down 6.9% in April theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.